A 32-year-old multiparous woman in active labor is plotted on the partograph. She has crossed the action line at 7 cm dilation with slow progress over the last 3 hours. Her contractions are 2 per 10 minutes, each lasting 25 seconds. She has no contraindications to oxytocin. What is the drug of choice for augmentation at this stage?

Explanation

## Partograph Action Line and Oxytocin Augmentation **Key Point:** Crossing the action line on the partograph indicates severe delay in labor progress. Oxytocin remains the first-line augmenting agent even at the action line stage, provided there are no contraindications and the patient has not yet reached the threshold for operative delivery. ### Partograph Alert and Action Lines: Clinical Significance | Line | Position | Meaning | Action | |------|----------|---------|--------| | **Alert line** | 2–3 cm left of action line | Slow progress; risk of prolonged labor | Start oxytocin augmentation | | **Action line** | Reference line (0 cm) | Severe delay; high risk of obstructed labor | Continue/escalate oxytocin OR prepare for operative delivery | **High-Yield:** The action line is NOT an automatic indication to abandon oxytocin. Rather, it signals that if the patient has not progressed adequately with oxytocin augmentation, operative delivery (cesarean section or assisted vaginal delivery) should be considered. However, if oxytocin has not yet been optimized, augmentation should continue. ### Why Oxytocin Remains First-Line 1. **Proven efficacy:** Oxytocin increases the frequency and strength of uterine contractions in a dose-dependent, titrable manner. 2. **Rapid onset:** 2–3 minutes IV, allowing quick assessment of response. 3. **Reversibility:** Short half-life (~3 minutes) permits rapid discontinuation if hyperstimulation occurs. 4. **Safety profile:** When properly monitored with fetal heart rate and uterine activity assessment, oxytocin is safe. ### Prostaglandins: Why NOT First-Line in Active Labor | Agent | Onset | Duration | Uterine effect | Use in labor | Concern | |-------|-------|----------|---|---|---| | **Dinoprostone (PGE~2~)** | 10–30 min | 2–3 hours | Rhythmic | Induction/ripening | Slower onset; not for augmentation | | **Carboprost (15-methyl PGF~2~α)** | 1–3 min IM | 2–3 hours | Variable | Postpartum hemorrhage | Hypertension, bronchoconstriction; not for labor augmentation | | **Misoprostol (PGE~1~)** | 15–30 min | 4–6 hours | Variable | Induction/ripening | Unpredictable; slower than oxytocin | | **Oxytocin** | 2–3 min IV | 30–60 min | Rhythmic, titrable | Augmentation/induction | Gold standard | **Clinical Pearl:** Prostaglandins are reserved for cervical ripening (dinoprostone, misoprostol) or postpartum hemorrhage (carboprost). They are NOT used for labor augmentation because their onset is slower and their effect is less predictable than oxytocin. ### Decision Tree: Action Line Crossing ```mermaid flowchart TD A[Partograph: Crosses action line]:::outcome --> B{Oxytocin already started?}:::decision B -->|No| C[Start oxytocin augmentation]:::action B -->|Yes| D{Adequate response to oxytocin?}:::decision D -->|Yes| E[Continue oxytocin, monitor closely]:::action D -->|No| F{Contraindications to vaginal delivery?}:::decision F -->|No| G[Prepare for operative delivery]:::urgent F -->|Yes| H[Cesarean section]:::urgent C --> I[Titrate to 3 contractions/10 min, 40–60 sec duration]:::action I --> J{Progress in next 2–3 hours?}:::decision J -->|Yes| K[Continue labor support]:::outcome J -->|No| L[Reassess: operative delivery]:::urgent ``` **Mnemonic: OXYTOCIN FIRST** — **O**xytocin for augmentation → **X** (exclude contraindications) → **Y**es to alert/action line crossing → **T**itrate carefully → **O**bserve fetal well-being → **C**ontinue if progress → **I**f no progress, intervene operatively → **N**ever use ergot in labor.